Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Role of Macular Pigment Carotenoids in the Pathogenesis and Treatment of Macular Telangiectasia Type 2 (MacTel)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Paul S. Bernstein, University of Utah
ClinicalTrials.gov Identifier:
NCT01354093
First received: May 12, 2011
Last updated: May 8, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)